Fifth Third Bancorp Legend Biotech Corp Transaction History
Fifth Third Bancorp
- $25.4 Billion
- Q1 2024
A detailed history of Fifth Third Bancorp transactions in Legend Biotech Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 217 shares of LEGN stock, worth $9,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217
Previous 193
12.44%
Holding current value
$9,708
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$490 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$268 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$241 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$117 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$107 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.49B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...